Navigation Links
Ventas Grants Stock Awards to Promote Long-Term Retention and Reward Performance
Date:12/5/2007

bility of the Company's operators, tenants, borrowers and managers, as applicable, to maintain the financial strength and liquidity necessary to satisfy their respective obligations and liabilities to third parties, including without limitation obligations under their existing credit facilities; (d) the Company's success in implementing its business strategy and the Company's ability to identify, underwrite, finance, consummate and integrate diversifying acquisitions or investments, including those in different asset types and outside the United States; (e) the nature and extent of future competition; (f) the extent of future or pending healthcare reform and regulation, including cost containment measures and changes in reimbursement policies, procedures and rates; (g) increases in the Company's cost of borrowing; (h) the ability of the Company's operators and managers, as applicable, to deliver high quality services, to attract and retain healthcare personnel and to attract residents and patients; (i) the results of litigation affecting the Company; (j) changes in general economic conditions and/or economic conditions in the markets in which the Company may, from time to time, compete; (k) the Company's ability to pay down, refinance, restructure and/or extend its indebtedness as it becomes due; (l) the movement of interest rates and the resulting impact on the value of and the accounting for the Company's interest rate swap agreement; (m) the Company's ability and willingness to maintain its qualification as a REIT due to economic, market, legal, tax or other considerations; (n) final determination of the Company's taxable net income for the year ending December 31, 2007; (o) the ability and willingness of the Company's tenants to renew their leases with the Company upon expiration of the leases and the Company's ability to relet its properties on the same or better terms in the event such leases expire and are not renewed by the existing tenants; (p) risks associ
'/>"/>
SOURCE Ventas, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
2. Ventas Board Names Ronald G. Geary Audit Committee Chair; Appoints Douglas Crocker II to Fill Vacancy on Audit Committee
3. Ventas Announces 2007 Third Quarter Earnings Release Date and Conference Call
4. Ventas Appoints Brush SVP - Senior Housing Development and Operations
5. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
6. U.S. Labor Department Awards $10.1 Million for Safety and Health Training Grants
7. Sunesis Pharmaceuticals Reports New Option Grants Under NASDAQ Marketplace Rule 4350
8. American Cancer Society awards research grants to 109 investigators at 77 institutions nationwide
9. USAID Announces First Malaria Communities Program Grants
10. The Highmark Foundation Awards $580,000 in Highmark Healthy High 5 Grants to Four Non-Profit Organizations
11. KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...onal Pediatric AIDS Initiative Will Improve... WASHINGTON, Aug. 29 /PRNewswire-FirstCall/ -- Th... government, Baylor College of Medicine, the,gover...S. President,s,Emergency Plan for AIDS Relief (PEP... improve care and treatment for children with HIV/...
(Date:8/29/2008).../ -- Conseco Insurance Company, a life,and health ...y of its new,indexed universal life insurance pro...de potential with downside protection., ConsecoLi... offers the,opportunity for long-term cash buildup...ents can customize their coverage levels with eigh...
(Date:8/29/2008)...SNewswire/ -- The U.S. Department of,Labor propose...public to,see exactly what goes into agency risk a...r http://edocket.access.gpo.gov/2008/E8-20179.htm...st available evidence and,scientific data are used...ards regulating occupational exposure to toxins in...
(Date:8/29/2008)...SNewswire/ -- The following is a,statement by Matt... Kids:, For the second time in a month, Philip Mo... and promotion of a concert in a developing countr...ngaging in cigarette,marketing that appeals to chi...s been forced to withdraw from,an August 30 reunio...
Breaking Medicine News(10 mins):Health News:Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania 2Health News:Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania 3Health News:Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania 4Health News:ConsecoLifeOptions Launched by Conseco Insurance Company as New Universal Life Product 2Health News:Notice of Proposed Rulemaking on U.S. Department of Labor's Risk Assessment Procedures Published in Federal Register 2Health News:Philip Morris International Forced to Drop Another Concert Sponsorship; Philippines Health Department Applauded for Taking Action 2
...occus Aureus) is a bacteria resistant to certain a...ients who suffer //from weakened immune systems, e...own to spread because of poor hygiene. Countries l...ay, where MRSA has been relatively low and stable ...
...an children with AIDS, five Bulgarian Nurses and a...sion //in the Court of Appellations in Tripoli. ...pital aids made the outbreak possible since all th...ive results. But the Libyan authorities refused th...
...ng various opinions on the issue of doctors being ...atients //without fear of a ban. In its new draf... careful and remind them that the relationship wou...appropriate. In a move that nullifies the past p...
...rsity School of Medicine and colleagues finds it’s...lt medical procedures //about the dizzy feel of na...trongly affect how they respond to adversity – bot...d lead author Max E. Levine, Ph.D. ‘Being prepared...
Other Medicine News:Health News:Super-bug MRSA Getting Fitter And Out of Control 2Health News:Precautious Measure Help Tolerate Nausea In Patients 2Health News:Precautious Measure Help Tolerate Nausea In Patients 3
(Date:8/27/2008)...Spraying Set for Tonight in Parts of Bucks, Delawa..., Pa., Aug. 27 /PRNewswire-USNewswire/ -- After en...ial treatments, the Department of,Environmental Pr... protect,the public against the mosquito-borne Wes... administered between 8 p.m. and,midnight in porti...
(Date:8/27/2008)...rd Winning Research Team Makes Crucial Breakthroug...of Parkinson,s Disease, CHICAGO, Aug. 27 /PRNewsw...on today announced that scientists at The Universi...in the battle to slow or prevent the onset,of a ve...., The researchers have genetically produced the ...
(Date:8/27/2008)... - First Phase 3 data, from BLISS-52 trial, expec...l, BLISS-76, expected by fall 2009 -, ROCKVILLE, ...e,Sciences, Inc. (Nasdaq: HGSI ) today announced ...BLISS-76, the second of two pivotal Phase 3,random...) in patients with,active systemic lupus erythemat...
(Date:8/26/2008)... INDIANAPOLIS, Aug. 26 /- Semafore Ph... Seventh International Congress on Targeted,Therap...nal antiangiogenic,activity of vascular-targeted P...h VEGF and Bv8 signaling., PI3K is part of a very...has been shown to play a major role in cancer. Stu...
Breaking Medicine Technology:DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 2DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 3The University of Nottingham in the British Midlands Announces Breakthrough in Parkinson's Disease Research 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 3Surprise U S Supreme Court Decision Helps Michigan Citizens 13313 1mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 1mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 2mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 3mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 4mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 5mtvU 26 The Jed Foundation Go Beyond March Madness Spring Break 26 5th Anniversary of Iraq War Dedicating March Programming to College Students Me 13310 6RealSelf com Denies Lifestyle Lifts Trademark Claims and Files Countersuit 13307 1RealSelf com Denies Lifestyle Lifts Trademark Claims and Files Countersuit 13307 2Beauty com Partners With Fashion Designer Jenni Kayne 13304 1Beauty com Partners With Fashion Designer Jenni Kayne 13304 2Beauty com Partners With Fashion Designer Jenni Kayne 13304 3Beauty com Partners With Fashion Designer Jenni Kayne 13304 4
...led Findings Presented at 2007 APA Meeting Also Sh...axine Succinate, COLLEGEVILLE, Pa., May 21, 2007 /...e pooled analyses - one examining the,effect of de...,other on painful symptoms associated with major d...pooled analysis that examined the,effect of desven...
...t-hoc analysis shows nearly nine out of ten patien...at the end of 12 months, WASHINGTON, D.C., May 22,...III, open-label 12-14 month extension study (303),...gy (BSG) meeting,in Glasgow, Scotland in March 200...lerated in mild to moderate UC,patients. Today, se...
Other Medicine Technology:Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 2Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 3Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 4Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 5Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 6Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 2Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 3Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 4Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 5Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 6Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 7Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 8
...gnostics is a leading provider of immunofluorescen... that includes kits for autoimmune diseases, infec...onjugates and components. Our Impact IFA Test Syst...it sizes to choose from. Kit components include su...
...gnostics is a leading provider of immunofluorescen... that includes kits for autoimmune diseases, infec...onjugates and components. Our Impact IFA Test Syst...it sizes to choose from. Kit components include su...
...gnostics is a leading provider of immunofluorescen... that includes kits for autoimmune diseases, infec...onjugates and components. Our Impact IFA Test Syst...it sizes to choose from. Kit components include su...
...ELISA products make us a leader in this field. Wit...into the busy laboratory, our Infectious Disease E...n-to-run consistency. Our Infectious Disease ELISA...e range of serological assays including ToRCH, EBV...
Medicine Products: